The groundbreaking therapy of the medication represents a major breakthrough in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide185727.timeblog.net/77924822/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment